Subsidiary Companies
Empowering Healthcare Through a Specialized Network
Arena Life Science Holding operates through a network of specialized subsidiary companies, each focusing on a key area of the pharmaceutical and healthcare value chain. Together, these companies form a strong, integrated structure that allows the holding to deliver innovative, high-quality, and sustainable solutions to patients and partners.
Our Subsidiaries
01
Arena Pharmaceuticals
Focused on the research, development, and manufacturing of innovative medicines. Arena Pharmaceuticals pioneers the production of advanced therapeutic products, including generics, biotechnology-based drugs, and recombinant proteins, to meet the growing healthcare needs of the region.
02
Arena Trading & Importation
A trusted partner in global sourcing and importation, this company ensures access to high-quality international medicines and raw materials. Arena Trading plays a vital role in building bridges with global pharmaceutical leaders and bringing modern healthcare solutions to the Iranian market.
03
Arena Marketing & Distribution
Specialized in sales, marketing, and distribution, this subsidiary connects Arena’s products with healthcare professionals, hospitals, and pharmacies. Its mission is to provide patients with safe and effective medicines while creating value for partners through professional marketing strategies.
04
Arena Biotechnology
A cutting-edge unit dedicated to biotechnology and recombinant products. Arena Biotechnology focuses on research and clinical development of advanced biologics, including treatments for cardiovascular, metabolic, and autoimmune diseases.
05
Arena Research & Development
The backbone of innovation within the holding, this subsidiary invests in scientific projects, clinical studies, and regulatory advancements. It ensures that Arena Life Science remains at the forefront of pharmaceutical technology and innovation.
Our Shared Goals
All subsidiary companies of Arena Life Science Holding are aligned under a common vision:
To enhance access to affordable and innovative medicines.
To support national pharmaceutical independence.
To invest in science-driven solutions that improve public health.
To expand regionally and globally through partnerships and innovation.